These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 3189800

  • 1. Analysis of sorbitol, galactitol, and myo-inositol in lens and sciatic nerve by high-performance liquid chromatography.
    Miwa I, Kanbara M, Wakazono H, Okuda J.
    Anal Biochem; 1988 Aug 15; 173(1):39-44. PubMed ID: 3189800
    [Abstract] [Full Text] [Related]

  • 2. Determination of sorbitol and galactitol at the nanogram level in biological samples by high-performance liquid chromatography.
    Dethy JM, Callaert-Deveen B, Janssens M, Lenaers A.
    Anal Biochem; 1984 Nov 15; 143(1):119-24. PubMed ID: 6528989
    [Abstract] [Full Text] [Related]

  • 3. Lens hexitols and cataract formation during lactation in a woman heterozygote for galactosaemia.
    Brivet M, Migayron F, Roger J, Cheron G, Lemonnier A.
    J Inherit Metab Dis; 1989 Nov 15; 12 Suppl 2():343-5. PubMed ID: 2512439
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ, Sarges R, Aldinger CE, MacDonald DP.
    Adv Exp Med Biol; 1979 Nov 15; 119():347-56. PubMed ID: 115231
    [No Abstract] [Full Text] [Related]

  • 5. Measurements of tissue sorbitol in diabetes mellitus: enzyme method versus gas-liquid chromatography.
    Malone JI, Lowitt S.
    Metabolism; 1992 Feb 15; 41(2):224-7. PubMed ID: 1736046
    [Abstract] [Full Text] [Related]

  • 6. Rapid analysis of sorbitol, galactitol, mannitol and myoinositol mixtures from biological sources.
    Eades DM, Williamson JR, Sherman WR.
    J Chromatogr; 1989 May 05; 490(1):1-8. PubMed ID: 2503529
    [Abstract] [Full Text] [Related]

  • 7. Effect of pyruvate on lens myo-inositol transport and polyol formation in diabetic cataract.
    Beyer-Mears A, Diecke FP, Mistry K, Ellison C, Cruz E.
    Pharmacology; 1997 Aug 05; 55(2):78-86. PubMed ID: 9323307
    [Abstract] [Full Text] [Related]

  • 8. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
    Tomlinson DR, Sidenius P, Larsen JR.
    Diabetes; 1986 Apr 05; 35(4):398-402. PubMed ID: 2420664
    [Abstract] [Full Text] [Related]

  • 9. Two-step high-performance liquid chromatography method for the determination of myo-inositol and sorbitol.
    Lauro PN, Craven PA, DeRubertis FR.
    Anal Biochem; 1989 May 01; 178(2):331-5. PubMed ID: 2751095
    [Abstract] [Full Text] [Related]

  • 10. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
    Malamas MS, Hohman TC, Millen J.
    J Med Chem; 1994 Jun 24; 37(13):2043-58. PubMed ID: 8027986
    [Abstract] [Full Text] [Related]

  • 11. Stable isotope dilution analysis of galactitol in amniotic fluid: an accurate approach to the prenatal diagnosis of galactosemia.
    Jakobs C, Warner TG, Sweetman L, Nyhan WL.
    Pediatr Res; 1984 Aug 24; 18(8):714-8. PubMed ID: 6433315
    [Abstract] [Full Text] [Related]

  • 12. Effect of SG-210, a novel aldose reductase inhibitor, on impaired polyol pathway in rats received diabetic manipulations.
    Horie S, Nagai H, Yuuki T, Narita Y, Tsuda Y, Nakajima T, Nakamura N.
    J Diabetes Complications; 1998 Aug 24; 12(3):163-9. PubMed ID: 9618072
    [Abstract] [Full Text] [Related]

  • 13. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
    Finegold D, Lattimer SA, Nolle S, Bernstein M, Greene DA.
    Diabetes; 1983 Nov 24; 32(11):988-92. PubMed ID: 6416910
    [Abstract] [Full Text] [Related]

  • 14. The effects of 5% and 25% galactose diets on lens polyols, glutathione and protein glycation in male and female pigs.
    Birlouez-Aragon I, Alloussi S, Morawiec M, Fevrier C.
    Curr Eye Res; 1989 May 24; 8(5):449-57. PubMed ID: 2500302
    [Abstract] [Full Text] [Related]

  • 15. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH, Ross IS.
    Br J Exp Pathol; 1988 Oct 24; 69(5):697-702. PubMed ID: 3143396
    [Abstract] [Full Text] [Related]

  • 16. Development of potent aldose reductase inhibitors having a hydantoin structure.
    Miwa I, Hirano M, Inagaki K, Belbeoc'h C, Okuda J.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2789-94. PubMed ID: 3115267
    [Abstract] [Full Text] [Related]

  • 17. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy.
    Sredy J, Sawicki DR, Notvest RR.
    J Diabet Complications; 1991 Sep 01; 5(1):42-7. PubMed ID: 1830318
    [Abstract] [Full Text] [Related]

  • 18. The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia.
    Segawa M, Hirata Y, Fujimori S, Okada K.
    Metabolism; 1988 May 01; 37(5):454-60. PubMed ID: 3285132
    [Abstract] [Full Text] [Related]

  • 19. Galactitol is not a cause of senile cataract.
    Arola H, Sillanaukee P, Aine E, Koivula T, Isokoski M.
    Graefes Arch Clin Exp Ophthalmol; 1992 May 01; 230(3):240-2. PubMed ID: 1597290
    [Abstract] [Full Text] [Related]

  • 20. Retinal polyol and myo-inositol in galactosemic dogs given an aldose-reductase inhibitor.
    Kern TS, Engerman RL.
    Invest Ophthalmol Vis Sci; 1991 Dec 01; 32(13):3175-7. PubMed ID: 1748548
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.